prednisolone phosphate has been researched along with Inflammation in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| d'Engelbronner, JC; de Wit, B; Kros, A; Papadopoulou, P; Schaaf, MJM; van Hage, P; Xie, Y | 1 |
| Hofkens, W; Schelbergen, R; Storm, G; van den Berg, WB; van Lent, PL | 1 |
| Banciu, M; Metselaar, JM; Schiffelers, RM; Storm, G | 1 |
| Boekhoven, RW; Kluza, E; Nicolay, K; Schiffelers, RM; Schmid, S; Storm, G; Strijkers, GJ; van der Schaft, DW; Yeo, SY | 1 |
| Apt, L; Isenberg, SJ; Voo, I | 1 |
1 trial(s) available for prednisolone phosphate and Inflammation
| Article | Year |
|---|---|
A randomized clinical trial of the nonsteroidal eyedrop diclofenac after strabismus surgery.
Topics: Administration, Topical; Adolescent; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Female; Humans; Inflammation; Male; Oculomotor Muscles; Ophthalmic Solutions; Postoperative Complications; Prednisolone; Strabismus; Wound Healing | 1998 |
4 other study(ies) available for prednisolone phosphate and Inflammation
| Article | Year |
|---|---|
Two Types of Liposomal Formulations Improve the Therapeutic Ratio of Prednisolone Phosphate in a Zebrafish Model for Inflammation.
Topics: Animals; Anti-Inflammatory Agents; Glucocorticoids; Inflammation; Liposomes; Polyethylene Glycols; Prednisolone; Tissue Distribution; Zebrafish | 2022 |
Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation.
Topics: Animals; Antigen-Antibody Complex; Antigens; Arthritis, Experimental; Biomarkers; Cell Differentiation; Female; Gene Expression Profiling; Inflammation; Liposomes; Macrophage Activation; Macrophages; Mice; Phenotype; Prednisolone; Synovial Membrane | 2013 |
Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice.
Topics: Animals; Budesonide; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Colonic Neoplasms; Dexamethasone; Dose-Response Relationship, Drug; Drug Delivery Systems; Endothelium, Vascular; Glucocorticoids; Inflammation; Injections, Subcutaneous; Liposomes; Male; Melanoma, Experimental; Methylprednisolone; Mice; Mice, Inbred C57BL; Nanomedicine; Neovascularization, Pathologic; Prednisolone; Receptors, Glucocorticoid; Time Factors; Tumor Burden; Umbilical Veins | 2008 |
Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Cell Line, Tumor; Glucocorticoids; Humans; Inflammation; Liposomes; Macrophages; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasms; Prednisolone | 2011 |